Results 131 to 140 of about 118,635,816 (237)

PB2323: ACQUIRED HEMOPHILIA: A CASE REPORT

open access: yesHemaSphere, 2022
N. Haddad, S. ABDI
doaj   +1 more source

Factor VIII inhibitors demonstrate type I or type II kinetics in high‐titre alloantibodies and autoantibodies

open access: yesClinical and Translational Discovery, Volume 6, Issue 5, October 2026.
The inhibitor kinetics type cannot be used by itself to determine auto‐ versus allo‐anti‐FVIII antibody type. To characterise inhibitor kinetics in inherited haemophilia A (HA) and acquired haemophilia A (AHA) patients in our centre, results show that inhibitors for both HA alloantibodies and AHA autoantibodies may exhibit either type I or type II ...
Cuicui Qiao   +10 more
wiley   +1 more source

Acquired Hemophilia

open access: yesInternal Medicine, 2015
Kimura, Kenji   +3 more
openaire   +3 more sources

Hemophilia, HIV and AIDS : perspectives in living : workshop study guide / John (Jack) R. McDonald, Jonathan Cooper

open access: yes, 1991
Prepared by the World Federation of Hemophilia in collaboration with the World Health Organization79 ...
World Health Organization   +3 more
core  

A case of acquired hemophilia A

open access: yes, 2013
We describe the case of a 82 years old female, who has been referred to the emergency department for a grosstrauma of the right knee after an accidental fall.
Ippolito, L., LIPPI, Giuseppe
core   +1 more source

Acquired Hemophilia Developing After Whipple Operation

open access: yesActa Haematologica Oncologica Turcica
Acquired hemophilia A (AHA) is a rare bleeding disorder. It is caused by autoantibodies produced against endogenous coagulation factors, without a family history of hemophilia. The incidence has been reported as 1.4 per million.
Nebi Acar, İsmail Hasırcı
doaj   +1 more source

Human biomarker navigator

open access: yesiMeta, Volume 5, Issue 5, October 2026.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

Time‐ and Temperature‐Dependent Response of Acquired FV Inhibitors: Implications for Laboratory Diagnosis and Clinical Management

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 20, October 2026.
This in vitro workflow illustrates the time‐and temperature‐dependent behavior of acquired FV inhibitors. Patient plasma was centrifuged and serially diluted, followed by parallel incubation at room temperature and 37°C. Serial measurements of APTT mixing test and residual FV activity were recorded across incubation time points to monitor inhibitor ...
Lihua Zhang   +6 more
wiley   +1 more source

Teaching Cell and Gene Therapy in Genetic Counseling Programs: Survey Findings and Suggested Practical Resources for Integration

open access: yesJournal of Genetic Counseling, Volume 35, Issue 5, October 2026.
ABSTRACT As cell and gene therapies (CGTs) advance through clinical trials into clinical practice, it becomes increasingly important for genetic counselors (GCs) to understand these therapeutics to discuss them with patients. Despite the apparent need for GCs to obtain CGT‐related education, little is known about the training GCs receive on CGT topics ...
Mariel Sebby   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy